Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer.
第一作者:
W,Albrecht
第一单位:
Department of Urology, Rudolfstiftung, Juchgasse 25, Vienna A 1030, Austria. walter.albrecht@kar.magwien.gv.at
作者:
医学主题词
投药, 口服(Administration, Oral);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);疾病恶化(Disease Progression);抗药性, 肿瘤(Drug Resistance, Neoplasm);雌氮芥(Estramustine);人类(Humans);输注, 静脉内(Infusions, Intravenous);男(雄)性(Male);前列腺特异抗原(Prostate-Specific Antigen);前列腺肿瘤(Prostatic Neoplasms);存活率分析(Survival Analysis);长春碱(Vinblastine)
DOI
10.1038/sj.bjc.6601468
PMID
14710214
发布时间
2022-03-09
- 浏览17
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



